ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,256.00
1.64%
Dow Jones
38,239.66
0.40%
Brent Oil
88.16
0.01%
Bitcoin
63,939.20
-0.85%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Capricor Therapeutics Inc (CAPR)

  7. Capricor Therapeutics Inc (CAPR) News

Capricor Therapeutics Inc

Capricor Therapeutics Inc (CAPR)

Caprock Mining Corp
5.43
0.28
( 5.44% )
Updated: 15:59:44
Delayed by 15 minutes

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

CAPR News

Official News Only

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
March 11 2024
CAPR (5.44%)

Form 8-K - Current report
Edgar (US Regulatory)
February 29 2024
CAPR (5.44%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
February 16 2024
CAPR (5.44%)

Form 8-K - Current report
Edgar (US Regulatory)
January 11 2024
CAPR (5.44%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 04 2024
CAPR (5.44%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 04 2024
CAPR (5.44%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 04 2024
CAPR (5.44%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
January 04 2024
CAPR (5.44%)

CAPR Discussion

View Posts
staynafloat staynafloat 2 days ago
Capricor announces positive Type-B meeting with FDA for CAP-1002 program for DMD. We will host a webcast to discuss this meeting and the latest program updates on Monday, April 29 at 8:30 am ET. #CAPR #CAP1002 #DMD > Click here to view the press release > https://t.co/cNGDQ7zL34 pic.twitter.com/gVNLVPMJNS— Capricor Therapeutics (@Capricor) April 24, 2024
👍️0
starkd748 starkd748 2 weeks ago
Lol I sold it for a little profit mon
👍️0
PARker1703 PARker1703 2 weeks ago
Maybe after a R/S
👍️0
starkd748 starkd748 3 weeks ago
Thanks looks like 8s coming here
👍️0
enthalpy enthalpy 1 month ago
Nice move on VERI.
👍️0
starkd748 starkd748 1 month ago
I loaded VERI instead
👍️0
starkd748 starkd748 1 month ago
Gl I loaded instead
👍️0
enthalpy enthalpy 1 month ago
Its going to 8 based on the weekly chart.
👍️0
starkd748 starkd748 1 month ago
Fell off a cliff today
👍️0
ed3/6me ed3/6me 1 month ago
Sold last at 6 bought bach at 4 so have a few more shares. Not like Enthalpy
👍️0
GreedyAgorist GreedyAgorist 1 month ago
You did not sell at 6 this time around, I hope. : - )
I added some shares under 6, because waiting for a big dip was not working. Patience is a virtue or so I've heard, but... I've had to add more 7.5 strikes to my options orders. I thought we could enjoy hanging around 5 for a while, but this thing is not accommodating that plan.

Is everyone enjoying this steady climb? We are just pennies away from being 100% up from the low for the year and yet this ticker is not on the breakout board. Which is good. Hitting #1 on the Hot Board is nearly always a sell signal.
👍️0
starkd748 starkd748 1 month ago
Haha looks like it
👍️0
enthalpy enthalpy 1 month ago
I think it get to 8 next week or so. We will see!!! Gltu!!!
👍️0
starkd748 starkd748 1 month ago
I'm waiting for 4s for a flip lol...Looks bearish
👍️0
enthalpy enthalpy 1 month ago
I doubled my position in the 4s. We will see. Secretly hoping for a green light on AA BLA in some form. So many other companies have a 500 million or billion dollar market cap and capr is right there but beaten down. At point it will get discovered.
👍️0
Volcano Volcano 2 months ago
I told you all
1000% runner here
👍️0
ed3/6me ed3/6me 2 months ago
would be a bigger player with my other holdings cooperation. Do not have volcanos view but feel it is a great vehicle for slow steady progress.
👍️0
enthalpy enthalpy 2 months ago
Hey Ed this is probably going to 8 this month at a minimum. Fingers crossed.
👍️0
ed3/6me ed3/6me 2 months ago
Sold some at 6 re bought at 4 so more shares and money
👍️0
GreedyAgorist GreedyAgorist 2 months ago
How did that work out for you, ed? Did you get some 5's assigned to you last month? I only picked up another 100 shares in February, after doing the same in January. It was December when I increased my position here by 60%. Now all those shares are up for grabs at 5. We will find out in 10 days if that is a bargain or not. At worst it will be a 25% gain in 3 months.

I only have one position in cash covered puts. Those will also expire on the 15th. It will be like scoring a 20% dividend out of something that does not pay a dividend.* Wish I had more put positions; I will the next time this "pos" dips. BTW, I trade this in an IRA, so no Wash Sale worries. I won't presently become a millionaire like Volcano. But maybe future me will.

Obvious statement: I am not ed3/6me's financial advisor or anyone else's. Just demonstrating how you can milk a ticker for almost monthly income without it being a blue chip dividend payer. I can't say it removes those anxious feelings you get when it dumps (or pumps), but it will remove some cash off the table.

*I could use more such scores to keep up with inflation; you know, just in case Biden scapegoating evil corporations doesn't do the trick.
👍️0
staynafloat staynafloat 2 months ago
Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy

SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- – Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, announced today that the Company has been granted an in-person Type-B meeting with the U.S. Food & Drug Administration (FDA) scheduled for late March. In the upcoming meeting with the FDA, the Company intends to discuss its proposed chemistry, manufacturing and controls (CMC) plans for commercial launch, if approved which may enable opportunities to expedite the pathway to a Biologics License Application (BLA) submission. The Company has previously been granted Regenerative Medicine Advanced Therapy (RMAT) and orphan drug designations for the use of CAP-1002 in Duchenne muscular dystrophy (DMD) and these designations enable sponsors to work closely with the FDA and receive its guidance on potential expedited pathways for approval.

“At this time, with our pivotal Phase 3, HOPE-3 trial fully enrolled in Cohort A and top-line data expected in the fourth quarter of this year, we believe that discussing our CMC plans for potential commercialization with the FDA will allow us the opportunity to bring CAP-1002 to patients in the most expeditious manner possible for patients in need,” said Linda Marbán, Ph.D., Capricor’s chief executive officer. “At Capricor, we remain focused on getting to approval as quickly as possible and we look forward to providing more details after this meeting.”

https://www.capricor.com/investors/news-events/press-releases/detail/271/capricor-therapeutics-announces-upcoming-type-b-meeting
👍️0
steadykickin steadykickin 2 months ago
https://www.capricor.com/investors/news-events/press-releases/detail/270/capricor-therapeutics-to-present-fourth-quarter-and-full February 29.
👍️0
Boom2013 Boom2013 2 months ago
https://www.capricor.com/investors/news-events/press-releases/detail/269/capricor-therapeutics-announces-manufacturing-scale-up-of
👍️0
steadykickin steadykickin 2 months ago
Capricor is pleased to be featured in a Scientific Session being held today at the International Duchenne Parent Project Italy Conference in Rome. To view the full agenda and additional details on the session please, click here: https://t.co/nOg382Rcj3 pic.twitter.com/pNg2sdUuHk— Capricor Therapeutics (@Capricor) February 17, 2024
👍️0
ed3/6me ed3/6me 2 months ago
Wrong
👍️0
stockplayer-11 stockplayer-11 2 months ago
Looks like nobody is interested in this shitty scam that'll never see FDA approval
👍️0
stockplayer-11 stockplayer-11 2 months ago
Damn your dumb ass can't even form a complete sentence.
👍️0
Volcano Volcano 2 months ago
Bcs you are ignorant and dumb
Why do you think huge Japanese bio firm made a deal?
They are much smarter than you dumbo
👍️0
stockplayer-11 stockplayer-11 2 months ago
You will not be be a millionaire. Will be no FDA approvals. You've been warned
👍️0
Volcano Volcano 2 months ago
I have huge shares here
I will be multi millionaire this year
I am so happy to hold long term
This is the year for FDA approval
👍️0
Volcano Volcano 3 months ago
It is coming
Be patient
We will be millionaires this year
$100 upon FDA approval
👍️0
PARker1703 PARker1703 3 months ago
When????? Been holding this pos for two years
👍️0
Volcano Volcano 3 months ago
Super huge news
👍️ 1
enthalpy enthalpy 3 months ago
K.
👍️0
PARker1703 PARker1703 3 months ago
Because the pumpers stopped posting
👍️0
enthalpy enthalpy 3 months ago
Fda meeting will happening shortly. Hopefully the get the greenlight this time.
👍️ 1
enthalpy enthalpy 3 months ago
On what grounds?
👍️0
ed3/6me ed3/6me 3 months ago
This unfunded part is their actual worth. If it gets teeth...they are going to the moon
👍️0
peterus peterus 3 months ago
going under 3s next few weeks
👍️0
dia76ca dia76ca 3 months ago
Steady progress on DMD is great. But the elephant in the room are the partnerships for the Exosome platforms.
Here is what the company has said...
"Exosome-Based Therapeutics and Vaccines (Preclinical): We are focused on developing a precision-engineered exosome platform technology that has the ability to deliver defined sets of effector molecules which exert their effects through defined mechanisms of action. We recently published preclinical data on our StealthXTM platform showing the rapid development of a recombinant protein-based.... At this time, we are developing vaccines and therapeutics for infectious diseases, monogenic diseases and other potential indications. Our platform builds on advances in fundamental RNA and protein science, targeting technology and manufacturing, providing us the opportunity to potentially build a broad pipeline of new therapeutic candidates. Our current strategy is FOCUSED on SECURING PARTNERS who will provide capital and additional resources..."
👍️0
dia76ca dia76ca 3 months ago
I forgot to add that they will also earn a Priority Review Voucher (PRV) which have sold recently for $110 million.
👍️0
enthalpy enthalpy 3 months ago
Lol well im okay with it. No reason really to go down. Ill hold out Q4 is almost here.
👍️0
dia76ca dia76ca 3 months ago
The recent $10 million milestone is only the start. There is another $90 million coming upon approval. And another $600 million in future milestones. And the ROW rights outside US and Japan should be significant. And very few shares out. Future exosome partnerships could be huge...with buy-out potential anytime IMO.
👍️0
peterus peterus 3 months ago
sell the news lol
👍️0
ed3/6me ed3/6me 3 months ago
Good for us . Right Enthalpy!
👍️0
PARker1703 PARker1703 3 months ago
You get 10mil and the stock goes down….pos
👍️0
enthalpy enthalpy 4 months ago
It is volcano time. Fingers crossed next 2 weeks we get some updates.
👍️0
ed3/6me ed3/6me 4 months ago
Trying your way
Y
👍️0
Volcano Volcano 4 months ago
I am looking forward to $100 price target this year
Pps will keep going up with the anticipation of BLA next month
I feel FDA will approve BLA this time
👍️0
ed3/6me ed3/6me 4 months ago
see this is finally getting recognised as what its potential is in the market. regenerative science sees potential here for rebuilding cells on a molecular level and this can springboard that research into all aspects of medicine as its basic potential to booster all known treatment plans going forward. read the research and make your own determination. I will be here till its true value is unlocked.
👍️0

Your Recent History

NASDAQ
CAPR
Capricor Therapeutics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved